Cowboy State Daily

Secrets In the Walls: Cheyenne's Atlas Theatre Renovation Uncovers New Mysteries

If a novelist was dreaming up cool props for a haunted theater, they couldn’t beat what a renovation crew found hiding in the ...
Blockonomi

Replimune (REPL) Shares Plunge 19% as FDA Issues Second Rejection for Melanoma Treatment

Replimune (REPL) stock plunged 19% after FDA issued second rejection of RP1 melanoma immunotherapy, citing inadequate trial design and controls.
The Manila Times

Dupixent® (dupilumab) Approved in the U.S. as the First Biologic Medicine for Young Children with Uncontrolled Chronic Spontaneous Urticaria (CSU)

Approval for children aged 2 to 11 years with CSU who remain symptomatic despite H1 antihistamine treatment based primarily on data from the LIBERTY-CUPID clinical trial program ...
Yahoo Malaysia

FDA-approved cancer drug may treat drug-resistant herpes

A drug long used to fight cancer may soon take on a very different role. Researchers at the University of Illinois Chicago ...
PharmiWeb

Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria

Approval for children aged two to 11 years with CSU who remain symptomatic despite H1 antihistamine treatment based primarily on data from the LIBERTY-CUPID clinical study programCSU is a chronic skin ...

Regeneron Pharmaceuticals, Inc.: Dupixent (dupilumab) Approved in the U.S. as the First Biologic Medicine for Young Children with Uncontrolled Chronic Spontaneous Urticaria (CSU)

Approval for children aged 2 to 11 years with CSU who remain symptomatic despite H1 antihistamine treatment based primarily on data from the LIBERTY-CUPID clinical trial program CSU is a chronic skin ...

Doctors Dismissed Her Encephalitis Symptoms as a UTI—It Nearly Cost Her Life

You may not have heard of Helen Edwards yet, but the 74-year-old grandmother could save your life. Her story went viral after ...
The Manila Times

Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU)

Approval in CSU for children 2 to 11 years of age is based on data from the LIBERTY-CUPID clinical trial program, including an extrapolation of efficacy data showing that Dupixent significantly reduce ...
The Western Telegraph

Helen's family want encephalitis symptoms to be known

Helen Edwards, 74, went from flu-like symptoms to a life-changing brain injury after encephalitis linked to the cold sore ...

‘The Pitt’: What Is Viral Meningitis, and What Does It Have To Do With Dr. Al-Hashimi’s Seizures?

Viewers have been suspecting for much of this season that Dr. Al-Hashimi was suffering from some sort of neurological disorder, as she was caught by the camera multiple times seemingly staring off ...

Regeneron Pharmaceuticals, Inc.: Dupixent (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU)

Approval in CSU for children 2 to 11 years of age is based on data from the LIBERTY-CUPID clinical trial program, including an extrapolation of efficacy data showing that Dupixent significantly reduce ...
The Hearty Soul on MSN

Surprising new research reveals what's really raising your dementia risk

Most people picture dementia as something that creeps up in old age, something that belongs to a distant future most of us ...